Search Results - "Breithaupt, Kirstin"

Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) by Thuss-Patience, Peter C, Kretzschmar, Albrecht, Bichev, Dmitry, Deist, Tillman, Hinke, Axel, Breithaupt, Kirstin, Dogan, Yasemin, Gebauer, Bernhard, Schumacher, Guido, Reichardt, Peter

“…Abstract Background The value of second-line therapy for metastatic gastric cancer is unclear. So far there are no randomised phase III data comparing…”
Get full text

RAP: A phase II trial with ramucirumab, avelumab, and paclitaxel as second line treatment in gastro-esophageal adenocarcinoma of the arbeitsgemeinschaft internistische onkologie (AIO) by Högner, Anica, Breithaupt, Kirstin, Stein, Alexander, Hinke, Axel, Lorenz, Mario, Al-Batran, Salah-Eddin, Thuss-Patience, Peter C.

“…Abstract only TPS4148 Background: Combination of ramucirumab and paclitaxel resembles the standard treatment option in second line therapy with improvement of…”
Get full text

Pazopanib with 5‐FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase‐II study—The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO‐STO‐0510 by Högner, Anica, Al‐Batran, Salah‐Eddin, Siveke, Jens T., Lorenz, Mario, Bartels, Prisca, Breithaupt, Kirstin, Malfertheiner, Peter, Homann, Nils, Stein, Alexander, Gläser, Dietrich, Tamm, Ingo, Hinke, Axel, Vogel, Arndt, Thuss‐Patience, Peter

“…VEGF inhibition in gastric cancer has a proven benefit in the second line setting. Pazopanib, an oral tyrosine kinase inhibitor, selectively inhibits VEGFR‐1,…”
Get full text

High Impact of Histopathological Remission for Prognosis after Perioperative Chemotherapy with ECF and ECF-Like Regimens for Gastric and Gastroesophageal Adenocarcinoma by Bichev, Dmitry, Treese, Christoph, von Winterfeld, Moritz, Breithaupt, Kirstin, Dogan, Yasemin, Schmidt, Sven C, Daum, Severin, Thuss-Patience, Peter C

“…Perioperative chemotherapy with epirubicin, cisplatin and 5-fluorouracil (5-FU) (ECF)-like regimens is the European standard for patients with adenocarcinoma…”
Get more information

Pazopanib and 5-FU/oxaliplatin as first-line treatment in advanced gastric cancer: PaFLO, a randomized phase II study from the AIO (Arbeitsgemeinschaft Internistische Onkologie) by Thuss-Patience, Peter C., Al-Batran, Salah-Eddin, Siveke, Jens T, Homann, Nils, Malfertheiner, Peter, Glaeser, Dietrich, Stein, Alexander, Tamm, Ingo, Daum, Severin, Potenberg, Jochem, Florschütz, Axel, Vogel, Arndt, Ridwelski, Karsten, Ritgen, Matthias, Geissler, Michael, Schmalenberg, Harald, Schlattmann, Peter, Lorenz, Mario, Breithaupt, Kirstin, Pichlmeier, Uwe

“…Abstract only…”
Get full text

PaFLO: Pazopanib with 5-fluorouracil, leucovorin, and oxaliplatin (FLO) as first-line treatment in advanced gastric cancer: A randomized phase II study of the  Arbeitsgemeinschaft internistische Onkologie (AIO) by Breithaupt, Kirstin, Bichev, Dmitry, Lorenz, Mario, Bohnen, Daniela, Dogan, Yasemin, Schlattmann, Peter, Al-Batran, Salah-Eddin, Moehler, Markus Hermann, Thuss-Patience, Peter C.

“…Abstract only TPS4138 Background: VEGF inhibition in gastric cancer shows promising improvement of remission rate and progression-free survival (Ohtsu et al.,…”
Get full text

Tumor necrosis factor alpha gene variants do not display allelic imbalance in circulating myeloid cells by Wienzek, Sandra, Kissel, Karin, Breithaupt, Kirstin, Lang, Christina, Nockher, Angelika, Hackstein, Holger, Bein, Gregor

“…Carriage of the TNF −308 A allele (rs1800629 A) has been associated with increased serum TNF-α levels, the development of sepsis syndrome, and fatal outcome,…”
Get full text

Hepatic Arterial Infusion Chemotherapy for Liver Metastases from Gastric Cancer: An Analysis in Western Patients by Flörcken, Anne, Schaefer, Claudia, Bichev, Dmitry, Breithaupt, Kirstin, Dogan, Yasemin, Schumacher, Guido, Gebauer, Bernhard, Riess, Hanno, Dörken, Bernd, Thuss-Patience, Peter C

“…Aims and background The advantage of administering chemotherapy by hepatic arterial infusion is the achievement of high drug concentrations in the liver…”
Get full text